People: Intra-Cellular Therapies Inc (ITCI.OQ)
Mr. Mark Neumann is Executive Vice President, Chief Commercial Officer of the Company. Mr. Neumann has served as Executive Vice President, Chief Commercial Officer of the Company since October 2018. From June 2014 to October 2018, Mr. Neumann served in leadership positions at Amgen, most recently serving as Vice President, Global Marketing. Before Amgen, from February 2014 to June 2014 Mr. Neumann served in a leadership position at AstraZeneca. Before joining AstraZeneca, from June 1988 to February 2014, he served at Bristol Myers Squibb Company in positions of increasing responsibility, including commercial leadership roles. Mr. Neumann is a licensed CPA (inactive) and received his bachelor’s degree from Lafayette College.
|Total Annual Compensation, USD||780,900|
|Restricted Stock Award, USD||799,991|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||933,446|
|Fiscal Year Total, USD||2,514,340|